Ono T - Search Results

1

Differential clinical significance of alpha(v)Beta(3) expression in primary lesions of acral lentiginous melanoma and of other melanoma histotypes.

Kageshita T, Hamby CV, Hirai S, Kimura T, Ono T, Ferrone S. Kageshita T, et al. Among authors: ono t. Int J Cancer. 2000 Mar 20;89(2):153-9. doi: 10.1002/(sici)1097-0215(20000320)89:2<153::aid-ijc9>3.0.co;2-1. Int J Cancer. 2000. PMID: 10754493

2

Alpha(v)beta3 expression on blood vessels and melanoma cells in primary lesions: differential association with tumor progression and clinical prognosis.

Kageshita T, Hamby CV, Hirai S, Kimura T, Ono T, Ferrone S. Kageshita T, et al. Among authors: ono t. Cancer Immunol Immunother. 2000 Aug;49(6):314-8. doi: 10.1007/s002620000124. Cancer Immunol Immunother. 2000. PMID: 10946813 Free PMC article.

3

Clinical significance of MART-1 and HLA-A2 expression and CD8+ T cell infiltration in melanocytic lesions in HLA-A2 phenotype patients.

Kageshita T, Kawakami Y, Ono T. Kageshita T, et al. Among authors: ono t. J Dermatol Sci. 2001 Jan;25(1):36-44. doi: 10.1016/s0923-1811(00)00104-3. J Dermatol Sci. 2001. PMID: 11154862

4

Loss of beta-catenin expression associated with disease progression in malignant melanoma.

Kageshita T, Hamby CV, Ishihara T, Matsumoto K, Saida T, Ono T. Kageshita T, et al. Among authors: ono t. Br J Dermatol. 2001 Aug;145(2):210-6. doi: 10.1046/j.1365-2133.2001.04336.x. Br J Dermatol. 2001. PMID: 11531781

5

Serum levels of sICAM-1 and 5-S-cysteinyldopa as markers of melanoma progression.

Hirai S, Kageshita T, Kimura T, Tsujisaki M, Imai K, Wakamatsu K, Ito S, Ono T. Hirai S, et al. Among authors: ono t. Melanoma Res. 1997 Feb;7(1):58-62. doi: 10.1097/00008390-199702000-00009. Melanoma Res. 1997. PMID: 9067966

6

Differential expression of MART-1 in primary and metastatic melanoma lesions.

Kageshita T, Kawakami Y, Hirai S, Ono T. Kageshita T, et al. Among authors: ono t. J Immunother. 1997 Nov;20(6):460-5. doi: 10.1097/00002371-199711000-00005. J Immunother. 1997. PMID: 9409451

7

Selective loss of human leukocyte class I allospecificities and staining of melanoma cells by monoclonal antibodies recognizing monomorphic determinants of class I human leukocyte antigens.

Kageshita T, Wang Z, Calorini L, Yoshii A, Kimura T, Ono T, Gattoni-Celli S, Ferrone S. Kageshita T, et al. Among authors: ono t. Cancer Res. 1993 Jul 15;53(14):3349-54. Cancer Res. 1993. PMID: 7686817

8

Association between sialyl Lewis(a) expression and tumor progression in melanoma.

Kageshita T, Hirai S, Kimura T, Hanai N, Ohta S, Ono T. Kageshita T, et al. Among authors: ono t. Cancer Res. 1995 Apr 15;55(8):1748-51. Cancer Res. 1995. PMID: 7712483

9

Human high molecular weight-melanoma associated antigen mimicry by mouse anti-idiotypic MAb MK2-23. Immunohistochemical analysis of the reactivity of anti-anti-idiotypic MAb with surgically removed melanoma lesions.

Kageshita T, Hirai S, Ono T, Ferrone S. Kageshita T, et al. Among authors: ono t. Int J Cancer. 1995 Jan 27;60(3):334-40. doi: 10.1002/ijc.2910600310. Int J Cancer. 1995. PMID: 7829240

10

Clinical relevance of ICAM-1 expression in primary lesions and serum of patients with malignant melanoma.

Kageshita T, Yoshii A, Kimura T, Kuriya N, Ono T, Tsujisaki M, Imai K, Ferrone S. Kageshita T, et al. Among authors: ono t. Cancer Res. 1993 Oct 15;53(20):4927-32. Cancer Res. 1993. PMID: 8104688

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,628 results

Search Page

Filters